|
◆ 会议时间:2019年9月6-7日 ◆ 会议地点:美国 芝加哥
◆ 会议简介:
2019美国血液学会(ASH)血液系统恶性肿瘤会议(MHM)将于2019年9月6-7日在美国芝加哥举行。会议的特点是汇集该领域的顶级专家,提供全面的临床内容,与同行进行互动交流,以及听取专家们提出的前沿科学数据,提供主要血液系统恶性肿瘤的最新信息:包括白血病,淋巴瘤,骨髓增生异常综合征,骨髓瘤,骨髓增殖性肿瘤。
美国血液学会(ASH)成立于1958年,是世界上最大的关注血液疾病病因与治疗的专业学会,在全球近100个国家拥有超过17,000名成员,ASH为世界各地致力于治疗血液疾病的临床医生和科学家服务。ASH通过促进对血液学的研究、临床护理、教育、培训和宣传,进而促进对血液、骨髓、免疫、止血和血管系统疾病的了解、诊断与防治。
ASH Meeting on Hematologic Malignancies September 6-7, 2019 Chicago, IL
Join us in Chicago for the 2019 ASH Meeting on Hematologic Malignancies, and gain knowledge that can help you make an immediate impact on your practice. This meeting will feature the top experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues in an intimate, small-group setting with no competing sessions. The program content will be structured as "How I Treat" presentations, which will showcase each speaker's evidence-based treatment approaches, present cutting-edge scientific data that can be translated into new strategies for diagnosis and treatment, and address what to do in cases where there is no data. Experts will provide out-of-the-box treatment approaches, answer challenging patient care questions during topic-based panel discussions, and engage in stimulating conversations on specific disease topics during Lunch with the Experts sessions.
◆ 参会对象: 政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|
|
|